Dear All,

On behalf of the International Pancreas and Islet Transplant Association (IPITA) and the Harvard Stem Cell Institute (HSCI) we are pleased to announce the 4th Summit on Stem Cell Derived Beta Cells to be held in Cambridge, MA, USA from April 24-25, 2023.

The workshop program offers world-renowned expert speakers presenting highly innovative science with state-of-the-art developments. Workshop topics will include:  

  • Identifying persistent challenges still such as developing beta cells with full physiologic function
  • Understanding the potential role of genome engineering to modify cells for therapeutic advantage
  • Identifying optimal transplant platforms and encapsulation technologies
  • Developing effective approaches to escape allo-, and autoimmunity 
  • Update on competing technologies including blastocyst complementation and gene edited xenografts
  • Presenting recent preclinical and clinical trial results.

We expect over 200 delegates and speakers representing leading experts and key opinion leaders in the field. Registration and abstract submission will open soon, and we look forward to your participation. 

We look forward to your participation,

Jon S. Odorico
MD, FACS, FAST

Program Committee Chair

James F. Markmann
MD, PhD

Summit Chair and IPITA Past President

Important Dates


November 30th, 2022
Launch abstract submission

January 5th, 2023
Registration opens

December 20th, 2023
Abstract submission closes

February 10th, 2023
Notification letters sent

March 3rd, 2023
Deadline for presenter registration

Organized by